Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma

NAActive, not recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

October 31, 2023

Study Completion Date

April 1, 2030

Conditions
Breast Cancer
Interventions
RADIATION

Radiation Therapy

"For the conventional fractionation arm: Each fraction will consist of 200 cGy per day. Total dose = 5000 cGy to the chest wall and 4600-5000 cGy to the lymph nodes.~For the hypofractionation arm: Each fraction consists of 266 cGy per day. Total dose = 4256 cGy to the chest wall and 3990 cGy to the lymph nodes."

Trial Locations (15)

20016

Johns Hopkins Medicine, Washington D.C.

81632

Vail Health, Edwards

94115

University of California, San Francisco, San Francisco

94305

Stanford University Medical Center, Stanford

98109

University of Washington, Seattle

06511

Yale Cancer Center, New Haven

04412

Eastern Maine Medical Center, Brewer

04074

Maine Medical Center, Scarborough

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston

01923

Massachusetts General Hospital/North Shore Center for Outpatient Care, Danvers

01757

Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) at Milford Regional Medical Center, Milford

02190

Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital, South Weymouth

02903

Lifespan/Rhode Island Hospital, Providence

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT03422003 - Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma | Biotech Hunter | Biotech Hunter